Biosante Pharmaceuticals Aktie
WKN DE: A1W15D / ISIN: US00182C1036
|
07.08.2026 13:00:05
|
ANI Pharmaceuticals, Inc. Profit Climbs In Q2
(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) revealed earnings for its second quarter that Increases, from the same period last year
The company's bottom line came in at $24.71 million, or $1.05 per share. This compares with $8.14 million, or $0.36 per share, last year.
Excluding items, ANI Pharmaceuticals, Inc. reported adjusted earnings of $47.63 million or $2.21 per share for the period.
The company's revenue for the period rose 25.9% to $266.04 million from $211.37 million last year.
ANI Pharmaceuticals, Inc. earnings at a glance (GAAP) :
-Earnings: $24.71 Mln. vs. $8.14 Mln. last year. -EPS: $1.05 vs. $0.36 last year. -Revenue: $266.04 Mln vs. $211.37 Mln last year.
-Guidance: Full year EPS guidance: $ 9.19 To $ 9.69 Full year revenue guidance: $ 1.080 B To $ 1.140 B
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biosante Pharmaceuticals Inc
|
06.08.26 |
Ausblick: Biosante Pharmaceuticals legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) | |
|
07.05.26 |
Ausblick: Biosante Pharmaceuticals stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net) | |
|
26.02.26 |
Ausblick: Biosante Pharmaceuticals stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) |
Analysen zu Biosante Pharmaceuticals Inc
Aktien in diesem Artikel
| Biosante Pharmaceuticals Inc | 65,50 | -8,39% |
|